Evidence map›Paper›PMID 35835638›Full record

ArticleBrain & development2022

Severe encephalopathy associated with SARS-CoV-2 Omicron BA.1 variant infection in a neonate.

Kenichi Tetsuhara, Satoshi Akamine, Yoshie Matsubara, Shunsuke Fujii, Wataru Kashimada, Kentaro Marutani, Michiko Torio, Yuya Morooka, Nozomu Hanaoka, Tsuguto Fujimoto and 6 more

Open access · bronzeAbstract readCase Reports
In one paragraph

Article in Brain & development, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.6field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Observational
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 2 institutions in 1 country.

Kenichi TetsuharaDepartment of Critical Care Medicine, Fukuoka Children's Hospital, Fukuoka, Japan. Electronic address: ken-tetsuhara@mti.biglobe.ne.jp.
Satoshi AkamineDepartment of Pediatric Neurology, Fukuoka Children's Hospital, Fukuoka, Japan.
Yoshie MatsubaraDepartment of Pediatric Neurology, Fukuoka Children's Hospital, Fukuoka, Japan.
Shunsuke FujiiDepartment of Critical Care Medicine, Fukuoka Children's Hospital, Fukuoka, Japan.
Wataru KashimadaDepartment of Cardiology, Fukuoka Children's Hospital, Fukuoka, Japan.
Kentaro MarutaniDepartment of Critical Care Medicine, Fukuoka Children's Hospital, Fukuoka, Japan.
Michiko TorioDepartment of Pediatric Neurology, Fukuoka Children's Hospital, Fukuoka, Japan; Department of General Pediatrics and Interdisciplinary Medicine, Fukuoka Children's Hospital, Fukuoka, Japan.
Yuya MorookaDepartment of General Pediatrics and Interdisciplinary Medicine, Fukuoka Children's Hospital, Fukuoka, Japan.
Nozomu HanaokaCenter for Emergency Preparedness and Response, National Institute of Infectious Diseases, Tokyo, Japan.
Tsuguto FujimotoCenter for Emergency Preparedness and Response, National Institute of Infectious Diseases, Tokyo, Japan.
Haruna Nakamura-MiwaCenter for Surveillance, Immunization, and Epidemiologic Research, National Institute of Infectious Diseases, Tokyo, Japan.
Satoru AraiCenter for Surveillance, Immunization, and Epidemiologic Research, National Institute of Infectious Diseases, Tokyo, Japan.
Keiko Tanaka-TayaCenter for Surveillance, Immunization, and Epidemiologic Research, National Institute of Infectious Diseases, Tokyo, Japan.
Kenji FurunoDepartment of General Pediatrics and Interdisciplinary Medicine, Fukuoka Children's Hospital, Fukuoka, Japan.
Yumi MizunoDepartment of Pediatric Infectious Disease and Immunology, Fukuoka Children's Hospital, Fukuoka, Japan.
Ryutaro KiraDepartment of Pediatric Neurology, Fukuoka Children's Hospital, Fukuoka, Japan.
Fukuoka Children's Hospital and Medical Center for Infectious Diseases · JPNational Institute of Infectious Diseases · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe coronavirus disease 2019 (COVID-19), including the Omicron variant, is less severe in children than in adults. To date, there has been no detailed description of COVID-19-associated severe encephalopathy due to the Omicron variant during the neonatal and early infantile periods. CASE PRESENTATION: During the outbreak of the Omicron variant, a 29-day-old male presented with a pale and ill appearance. The patient was intubated for mechanical ventilation owing to recurrent apnea, which subsequently turned out to be a breath-holding that may have been caused by seizure. In addition, nonconvulsive status epilepticus was observed. Total duration of repetitive seizure activities was approximately 30 min per hour when seizures were most severe. Brain magnetic resonance imaging (MRI) on day 14 revealed extensive hyperintensity in the T2 sequence, hypointensity in the fluid-attenuated inversion recovery (FLAIR) sequence in the deep and subcortical white matter, and diffusion restriction in the corpus callosum. The Omicron BA.1 variant of the severe acute respiratory syndrome coronavirus 2 was detected in his respiratory sample. Follow-up MRI on day 45 revealed multiple cystic cavitations.

conclusionAlthough COVID-19 is not severe in most children, life-threatening conditions such as COVID-19-associated severe encephalopathy can occur during the neonatal and early infantile periods.

Indexed as

Brain DiseasesCOVID-19AdultChildHumansInfant, NewbornMaleSARS-CoV-2SeizuresCoronavirus disease 2019 (COVID-19)EncephalomalaciaNeonateOmicron variantSevere encephalopathy

Identifiers

PMID35835638
PMCPMC9273474
OpenAlexW4285045586

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.